M.D., Ph.D., Director, National Personalized Medicine Program and National Cancer Control Center, Clalit Health Services, Israel; 100K Israeli Genomes Project
Dr. Rennert directs a national center in Israel which is responsible for research and implementation of the personalized medicine approach in the health system. With an MD (1984, Ben Gurion U, Israel) and PhD in Public Health (1988, UNC, Chapel Hill) he is a trained molecular epidemiologist and experienced public health genomics professional and has published extensively in these fields. His Center is responsible for approval of all molecular testing in Clalit Health Services – the largest health care provider in Israel and has more than 40,000 people under current research and a bio-bank with more than 400,000 aliquots of DNA, sera, lymphocytes and tumor tissue. Among his research responsibilities he is a member of the of the G2MC (The Global Genomic Medicine Collaborative) Steering Committee and is a leader of the Research and Translation Team of the recently established IHCC (International100K cohorts Consortium).